Soluble Immune Checkpoints and Anti‐ HLA Antibodies in Kidney Transplant Recipients: Associations With Kidney Function
Immunology · 2026
DOI: 10.1111/imm.70165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, 2026. Verfasst von Cemil Pehlivanoğlu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Institute of Graduate Studies in Health Sciences, Istanbul University, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Kidney Transplantation, HLA Antigens, Immune Checkpoint Proteins, Kidney. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Scientific Research Projects Coordination Unit of Istanbul University, Scientific and Technological Research Council of Türkiye (TÜBİTAK), Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.
Abstract (Originalsprache)
Kidney transplantation is the optimal treatment for end‐stage renal disease. Soluble immune checkpoints (sICs) may serve as key immune regulators and potential biomarkers in transplantation. In this study, frozen serum samples from kidney transplant recipients ( n = 30) at pre‐transplantation (day 0) and post‐transplantation (days 3 and 7), along with samples from healthy controls (HCs, n = 15), were analysed for sICs (sCD25, s4‐1BB, sCD86, active TGF‐β1, sCTLA‐4, sPD‐L1, sPD‐1, sTIM‐3, sLAG‐3, galectin‐9, sCD27, and sPD‐L2) using a flow cytometry‐based multiplex bead assay. To assess alloimmune sensitisation, anti‐HLA panel‐reactive antibody (PRA) levels were measured in transplant recipients. Kidney function was evaluated retrospectively by serum creatinine and estimated glomerular filtration rate (eGFR, CKD‐EPI). All data were analysed to investigate their associations with kidney function. Pre‐transplant patients had significantly higher serum levels of sCD25, sPD‐L1, sTIM‐3, Galectin‐9, sCD27, and sPD‐L2 compared to HCs. Post‐transplant, sCD25, sPD‐L1, sTIM‐3, Galectin‐9, sCD27, sPD‐L2, and sCD86 showed significant temporal changes. Conversely, s4‐1BB, sLAG‐3, sCTLA‐4, active TGF‐β1, and sPD‐1 levels showed no temporal changes and were comparable to HCs. Notably, PRA‐positive patients exhibited higher sTIM‐3 levels. Correlation and subgroup analyses based on eGFR revealed that higher levels sLAG‐3 and sCTLA‐4 levels were associated with better kidney function, while higher sCD25 and Galectin‐9 levels were linked with poorer function. These findings suggest a link between sICs and renal function in the early post‐transplant period, highlighting their potential as biomarkers and therapeutic targets. Future studies with larger cohorts are needed to evaluate their clinical utility in improving transplant outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Institute of Graduate Studies in Health Sciences, Istanbul University, Istanbul, Türkiye.
- Department of Immunology, Faculty of Medicine, Yeditepe University, Istanbul, Türkiye.
- Department of General Surgery, Faculty of Medicine, Yeditepe University, Istanbul, Türkiye.
- Department of Nephrology, Faculty of Medicine, Yeditepe University, Istanbul, Türkiye.
- Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Türkiye.
- Diabetes Application and Research Center, Istanbul University, Istanbul, Türkiye.
ORCID-Profile: Cemil Pehlivanoğlu, Fırat Demircan, Başak Aru, Süheyla Apaydın, Abdullah Demir, Rabia Tığlı, Gürkan Tellioğlu, Ali Osman Gürol, Gülderen Yanıkkaya Demirel
Förderung
- Scientific Research Projects Coordination Unit of Istanbul University
- Scientific and Technological Research Council of Türkiye (TÜBİTAK)
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
Zitieren
APA
Pehlivanoğlu, C., Demircan, F., Aru, B., Apaydın, S., Demir, A., Tığlı, R., Tellioğlu, G., Gürol, A. O., & Yanıkkaya Demirel, G. (2026). Soluble Immune Checkpoints and Anti‐ HLA Antibodies in Kidney Transplant Recipients: Associations With Kidney Function. Immunology. https://doi.org/10.1111/imm.70165
Vancouver
Pehlivanoğlu C, Demircan F, Aru B, Apaydın S, Demir A, Tığlı R, et al. Soluble Immune Checkpoints and Anti‐ HLA Antibodies in Kidney Transplant Recipients: Associations With Kidney Function. Immunology. 2026. doi:10.1111/imm.70165
BibTeX
@article{Pehlivanolu2026,
author = {Pehlivanoğlu, Cemil and Demircan, Fırat and Aru, Başak and Apaydın, Süheyla and Demir, Abdullah and Tığlı, Rabia and Tellioğlu, Gürkan and Gürol, Ali Osman and Yanıkkaya Demirel, Gülderen},
title = {Soluble Immune Checkpoints and Anti‐ HLA Antibodies in Kidney Transplant Recipients: Associations With Kidney Function},
journal = {Immunology},
year = {2026},
doi = {10.1111/imm.70165}
}
EUVIMED